|
Question for the HER2support crew at ASCO
Could you find out if there any presentation or report or information discussing whether raloxifene has demonstrated the same resistance problems that tamoxifen has, now that raloxifene has shown its effectiveness?
Because tamoxifen has such a long history and has been the drug of choice for premenopausal HR+ patients, it still seems to be accepted as the only option -- but does this make any sense in terms of HR+ HER2's?
AlaskaAngel
|
Threaded Mode